is jardiance a glp-1 receptor and the kidney: from physiology to pharmacology and outcomes in diabetes Targeting GLP-1, GIP & GCG

Important safety considerations include a boxed warning for medullary thyroid carcinoma (MTC) risk with most GLP-1 medications, which are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

FEBS Lett (1981) 129(1):12730

Patients should be cautious about products that promise rapid weight loss, dramatic appetite suppression, or results equal to prescription injections without medical supervision

They are not even close to the same thing

Can GLP-1s Treat OSA

Patients should understand that dose escalation protocols intentionally slow the initial response